Loading
Life sciences · Journal article
Frontiers in Nutrition · October 26, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Background Accelerated bone loss is often observed in postmenopausal women with breast cancer receiving long-term aromatase inhibitor (AI) therapy; particularly, there is a growing need for targeted nutritional interventions. Methods This multi-database bibliometric study evaluated 25 years of literature from 2000 to 2025 retrieved from the Web of Science Core Collection and Scopus. Following PRISMA guidelines, 768 publications were assessed using R-based analytical workflows to examine output trends, collaboration networks, thematic evolution, and citation impact. Results Annual scientific production expanded between 2005 and reached a peak in 2011, followed by a stable plateau of annual output through 2025. With strong institutional networks in North America and Europe, the United States was the productivity leader. A conceptual transition from isolated antiresorptive medications (bisphosphonates, denosumab) to an integrative bone microenvironment preservation strategy was suggested by keyword and thematic analyses. Keyword patterns suggested that Vitamin D and calcium are frequently integrated as universal baseline co-therapies, and topics including obesity, treatment-associated arthralgia, and survivorship exhibited high citation impact. Conclusion Studies on AI-associated bone loss (AIBL) have moved beyond routine BMD measurement to the structured co-management of micronutrients and metabolism, which may in turn guide future breast cancer survivorship research.